IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy
Biomaterials Science · 2025
DOI: 10.1039/d5bm00848d ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2025. Verfasst von Jinyang Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engin…. Hauptthemen laut MEDLINE: Nanoparticles, Immunotherapy, Interleukin-12, Tumor-Associated Macrophages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A versatile, coordinated nanoplatform (PEG/IL12-IA NPs) is prepared by cross-linking IL12 into the self-assembled HSA nanoparticles with ICG and Arg, which could promote TAM reprogramming and T cell-mediated immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engineering, Peking Union Medical College & Chinese Academy of Medical Scie…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Gao, W., & Ma, G. (2025). IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy. Biomaterials Science. https://doi.org/10.1039/d5bm00848d
Vancouver
Zhang J, Gao W, Ma G. IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy. Biomaterials Science. 2025. doi:10.1039/d5bm00848d
BibTeX
@article{Zhang2025,
author = {Zhang, Jinyang and Gao, Wenyue and Ma, Guilei},
title = {IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy},
journal = {Biomaterials Science},
year = {2025},
doi = {10.1039/d5bm00848d}
}
EUVIMED